Home » Revitalization » Affymetrix enters distribution agreement with Fisher Scientific for GeneAtlas System Affymetrix.

Affymetrix enters distribution agreement with Fisher Scientific for GeneAtlas System Affymetrix.

The GeneAtlas System is the 1st personal microarray answer to meet up the demand among life scientists for a user friendly and affordable method to interrogate the whole genome. Fisher Scientific includes a leading position in the life span sciences market and an unparalleled reach and a proven record of customer support and support. Now we have somebody with the industry’s strongest customer channel to take this technology to the broadest lifestyle scientist community, which is key to the GeneAtlas System’s achievement.The authors found that while Hispanics and blacks experienced similar levels of weight problems and insulin resistance, blacks had a lower prevalence of hepatic steatosis. They also found further evidence a regular serum ALT level gives little diagnostic or prognostic value when assessing sufferers for NAFLD. Almost 80 % of the subjects in this study with hepatic steatosis got normal serum ALT levels. Limitations of the scholarly study include possible underestimation of alcohol intake, since this was self-reported by the sufferers in the study. Also, the researchers cannot display for infectious disease and for that reason could not evaluate the influence of hepatitis C virus on hepatic steatosis. In conclusion, the authors statement, Understanding the mechanisms responsible for the ethnic variations in the prevalence of hepatic steatosis and steatosis-related liver injury might provide clues to the advancement of new therapeutic approaches for the prevention and treatment of this disorder.